Doctor profile · Federal record
Dr. Gary Aldrich, PA-C
Physician Assistant · Surgical Physician Assistant · Cedar Rapids, IA
- NPI 1629474978
- Accepts Medicare
- MIPS 84.7 / 100 · 2023
- 12 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
202 10Th St Se Ste 270
Cedar Rapids, IA 524032420
(319) 294-4319
fax (319) 294-4298 - Mailing address
-
801 York St
Manitowoc, WI 542204630
Credentials & registration
- NPI registered
- November 2014 — 12 yrs on file
- Profile last updated
- December 15, 2025
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- Iowa #134292 · North Carolina #001005368
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1629474978. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,828
Distinct HCPCS
10
Medicare allowed
$77,100
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 785 | 150 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 420 | 358 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 284 | 237 | $50 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 117 | 117 | $91 | |
11102 |
Biopsy of related skin growth, first growth | 75 | 73 | $80 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 49 | 47 | $46 | |
17110 |
Destruction of skin growth, 1-14 growths | 48 | 46 | $92 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 22 | 20 | $138 | |
11103 |
Biopsy of related skin growth, each additional growth | 17 | 12 | $41 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 11 | 11 | $59 |
In context: peer comparison
Among 13 peers in this city , average services per provider: 86. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$1,958
Transactions
90
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 19 | $405.12 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $246.49 | |
| Regeneron Healthcare Solutions, Inc. | 6 | $163.50 | |
| E.R. Squibb & Sons, L.L.C. | 14 | $156.11 | |
| GENZYME CORPORATION | 3 | $112.83 | |
| Lilly USA, LLC | 6 | $100.24 | |
| Janssen Biotech, Inc. | 5 | $88.79 | |
| Novartis Pharmaceuticals Corporation | 5 | $81.36 | |
| Organogenesis Inc. | 2 | $80.55 | |
| Incyte Corporation | 3 | $78.15 | |
| Arcutis Biotherapeutics, Inc. | 4 | $77.11 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69.88 | |
| Galderma Laboratories, L.P. | 4 | $66.49 | |
| Amgen Inc. | 2 | $57.75 | |
| PFIZER INC. | 3 | $56.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
228
Patients
145
Total drug cost
$52,090
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 60 | 32 | $1,383 |
| Triamcinolone Acetonide | Generic | 49 | 43 | $587 |
| Fluorouracil | Generic | 30 | 28 | $3,100 |
| Clobetasol Propionate | Generic | 27 | 17 | $1,639 |
| Mupirocin | Generic | 27 | 25 | $264 |
| Dupixent Pen (Dupilumab) | Brand | 12 | 0 | $43,486 |
| Fluconazole | Generic | 12 | 0 | $137 |
| Tacrolimus | Generic | 11 | 0 | $1,494 |
Frequently asked questions
What is Dr. Gary Aldrich's medical specialty?
Dr. Gary Aldrich practices Physician Assistant in Cedar Rapids, IA.
Where does Dr. Gary Aldrich practice?
Dr. Gary Aldrich practices at 202 10Th St Se Ste 270, Cedar Rapids, IA 524032420. Office phone: 3192944319.
What is Dr. Gary Aldrich's NPI?
Dr. Gary Aldrich's National Provider Identifier (NPI) is 1629474978, issued by NPPES.
Does Dr. Gary Aldrich accept Medicare assignment?
Yes. Dr. Gary Aldrich accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gary Aldrich commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.